Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

VFC's Stock House: Advanced Medical Isotope Corporation Banking On Expanded Distributino and Radiogel Technology

(Medical-NewsWire.com, September 20, 2012 ) New York, NY -- Advanced Medical Isotope Corporation (ADMD) is already a US-based manufacturer and distributor of medical isotopes and is also developing key technologies that may offer a superior alternative to the current standard of care for battling cancer with nuclear medicine.



In a Thursday report, VFC's Stock House, an information and research outlet that brings ideas and opens discussions to a broad spectrum of investors, identifies key point for optimism regarding the company and examines its speculative potential as an investment. Full report available at: http://vfcsstockhouse.com/blog/article/-advanced-medical-isotope-corporation-expanded-distribution-and-radiogel-technology-hold-the-keys-to-the-future



Advanced Medical Isotope Corporation (ADMD) has - through key partnerships, expanding distribution channels and the acquisition of a license to a novel cancer-fighting technology - well positioned itself to become a growth player in the field of nuclear medicine, specifically in the field of the production and distribution of medical isotopes. Medical isotopes are used in molecular imaging, therapy, and nuclear medicine to diagnose, manage and treat diseases and are deemed a hot item whenever discussed because of the geopolitical implications of non-nuclear nations attempt to enrich uranium for - ahem - solely medical purposes.



Advanced Medical is one of only a few companies in the United States manufacturing and distributing such isotopes and it's likely that business could quickly hit a growth spurt - not only through the company's own indigenous expansion and distribution efforts, but also because of the growing desire of the medical community in the US to use 'home grown' nuclear materials, not to mention increasing regulation that may force the community to do so anyway.



AMIC already offers a broad variety of isotopes and, as outlined in a recent quarterly report, is looking to expand its 'pipeline' of product offerings for its distribution network of customers that include - but is not limited to - national laboratories, hospitals, research facilities and universities.



Many of the company's isotopes are put to use through molecular imaging, or Positron Emission Tomography (PET), which enables Doctors and medical professionals to identify cancerous condictions well before detection means that search for tumor mass. Some of the radiopharmaceutical products based on the medical isotopes are also used in the early detection of certain cardiovascular indications and, as mentioned above, the demand for such products is growing, not shrinking. According to numbers identified in a recent company presentation and credited to the World Nuclear Association, the use of medical isotopes is growing at an annual rate of 10%.



That places AMIC right in the middle of a potential growth boom.



While production and distribution may encompass the company's core business model, AMIC is moving heavily into the field of treatment, too. The process of placing radioactive "seeds" in or near a cancerous tumor is known as brachytherapy, and AMIC is developing a pipeline based on such technology to augment the already-growing core business plan.



In April, the company acquired a license and numerous relating patents to an injectible radiogel technology that could have a significant impact on the next generation of fighting cancer. Using the radiogel technology doctors could deliver Yttrium-90 "microspheres" directly into cancerous tissue. Because the injectible polymer turns solid and holds the microspheres in place, there is little to no threat of any radiation escaping and damaging surrounding tissue. As described by Dr. Alan Walter, Chair of the AMIC Scientific Committee, in a presentation available on the company's home page, such a technology could be termed as using "smart bullets" to target cancerous cells.



Yttrium-90, in the form of Polymer seeds, is an already-established medical isotope with numerous applications in existing cancer treatment and has demonstrated effectiveness in combating head, neck, liver and prostate cancers, according to an above-linked company presentation. The radiogel application of Yttrium-90 could potentially 'storm the scene' in treating numerous cancer types with the intent of targeting those tumors in the hard-to-get to areas of the body that eliminates surgery as an option.



Both the Polymer seeds and the acquired the radiogel technology significantly boost the diversity of AMIC, offering a targeted path to enter the realm of caner treatment to augment the production, sales and distribution channels of its isotopes.



It's possible, based on previous expectations, that the Brachytherapy pipeline could hit market within a couple of years. At that point AMIC could either move forward with commercialization on its own or out-license the technology to someone else and use that revenue stream of royalties to fund the expansion of the core business.



Shares were up by eight percent on Wednesday, although volume was very light. That said, volume has been picking up significantly over the past few months and has tripled already once this year. Volume has also stormed in after the company's more relevant press releases, indicating that there are investors on the sidelines who either wait to play a quick trade or may be taking a 'wait and see' approach to playing this still-speculative stock.



Should the potential of the AMIC distribution network continue to expand and meet the growing demand for nuclear medicine - and should the polymer seeds and radiogel technology also hit market with momentum - then it's likely that the current ADMD share price could start to move. Currently, shares consistently trade for a few pennies above the twenty cents mark, give or take.



Based on the potential of the developing technology, already-available products and future product offerings, the current ADMD trading levels could serve as an opportune accumulation period to those looking at the risk/reward profile for the future. The current market cap of still under twenty million indicates that many investors are still unconvinced, but when searching for potential payoff picks on the bulletin board stocks, it pays off to be in while the stock is still moving along relatively unnoticed, as the best percentage gains to be had in any run start with being in place before the run starts.



That said, the stock market is risky business and there are no sure things, that's why it's up to each investor to conduct his or her own DD and invest accordingly.



Still a developing story worth monitoring.



Disclosure: No position.



Follow ADMD developments and other small cap stocks at VFCsStockHouse.com



Contact VFC's Stock House: vfc@vfcsstockhouse.com



Follow VFC's Stock House on Twitter: https://twitter.com/#!/VFCsStockHouse



'Like' VFC's Stock House on Facebook: http://www.facebook.com/pages/VFCs-Stock-House/143724412345213



About VFCsStockHouse.com:



VFC's Stock House is an information and research outlet that brings new ideas to the table and opens discussions for a broad spectrum of investors, with a strong focus on - but not limited to - biotech stocks, biopharma stocks, and pharmaceutical and healthcare stocks. VFC's Stock House provides individual company profiles, write-ups and reports as well as giving general insights and opinions into broader-market news. At the conclusion of most weeks, VFC's Stock House issues a "Weekly Stock Watch" that examines news items, stocks and stories that made headlines during the previous trading week, but may also make headlines or influence trends during the upcoming week as well. The information contained within the pages of VFCs Stock House are not intended to be taken as advice, but as a starting point where investors can follow up with their own DD and make informed and well thought-out investment decisions. For full disclaimer visit: http://vfcsstockhouse.com

VFC's Stock House

VFC

240-786-2111

vfc@vfcsstockhouse.com

Source: EmailWire.Com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News
Health News Headlines - Yahoo News
Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on top health stories.


Liberian voter turnout low as Ebola overshadows senate election
20 Dec 2014 at 1:42pm

By James Harding Giahyue MONROVIA (Reuters) - Turnout for Liberian parliamentary elections on Saturday appeared to be low as concerns about Ebola kept many voters at home. Polling stations were largely empty after voting began at 8 a.m. (3.00 a.m. ET) in the seafront capital Monrovia, with voters occasionally drifting in, despite precautions put in place by the National Elections Commission (NEC). Staff with temperature guns at polling stations checked voters for any signs of the hemorrhagic fever, which is spread via bodily fluids. ...


Child tests negative for Ebola at Chicago hospital
20 Dec 2014 at 12:33pm
(Reuters) - A child being monitored for Ebola in a Chicago hospital has been discharged after testing negative for the virus, the state health agency said on Saturday. Federal officials screening for Ebola at O'Hare International Airport in Chicago detected a fever in the child, who had been held in isolation at the University of Chicago Medical Center for monitoring since Friday. "Tests by the Illinois Department of Public Health confirmed a negative result for Ebola," the Illinois Department of Public Health said in a statement. ...


Liberia holds Senate vote amid Ebola fears
20 Dec 2014 at 11:04am

MONROVIA, Liberia (AP) ? Health workers carrying thermometers and sanitizers manned polling stations across Liberia on Saturday as voters cast their ballots in a twice-delayed Senate election that has been criticized for its potential to spread the deadly Ebola disease.



U.N.'s Ban urges end to discrimination against Ebola workers
20 Dec 2014 at 8:38am

By Matthew Mpoke Bigg CONAKRY (Reuters) - U.N. Secretary-General Ban Ki-moon on Saturday urged countries affected by the Ebola virus to avoid discriminating against healthcare workers fighting to end the disease. Ban was speaking in Guinea on the second day of a whistle-stop tour aimed at thanking healthcare workers of the countries at the heart of the epidemic. According to the latest World Health Organization figures, 7,373 people have died of Ebola in the three worst-affected countries, Liberia, Sierra Leone and Guinea. ...


Sierra Leone peacekeepers to leave Somalia mission
20 Dec 2014 at 8:34am
FREETOWN, Sierra Leone (AP) ? A Sierra Leone military official says the country is withdrawing from the African Union peacekeeping force in Somalia after being blocked from rotating its soldiers over concerns about the spread of Ebola.


WHO: Recorded Ebola deaths top 7,000
20 Dec 2014 at 7:20am

CONAKRY, Guinea (AP) ? The worst Ebola outbreak on record has now killed more than 7,000 people, with many of the latest deaths reported in Sierra Leone, the World Health Organization said as United Nations Secretary-General Ban Ki-moon continued his tour of Ebola-affected countries in West Africa on Saturday.



Child being observed at Chicago hospital to rule out Ebola
20 Dec 2014 at 6:52am

By Mary Wisniewski CHICAGO (Reuters) - A child who arrived in Chicago with a fever was under observation on Friday at a city hospital to rule out the Ebola virus, hospital officials said. Federal officials screening arriving passengers at O'Hare International Airport detected the fever, but no other symptoms of the disease, the University of Chicago Medical Center said in a statement. The patient was isolated under strict quarantine protocols until the child?s condition improves and a diagnosis is established, the hospital said. The child was in stable condition. ...



Ebola death toll in three African countries hits 7,373: WHO
20 Dec 2014 at 5:57am

GENEVA (Reuters) - The death toll from Ebola in the three worst-affected countries in West Africa has risen to 7,373 among 19,031 cases known to date there, the World Health Organization said on Saturday. The latest data, posted overnight on the WHO website, reflected nearly 500 new deaths from the worst ever outbreak of the hemorrhagic fever in Guinea, Liberia and Sierra Leone since previous WHO figures were issued on Dec. 17. Sierra Leone accounts for the most cases, 8,759, against 7,819 for Liberia. ...



UN's Ban urges end to discrimination against Ebola workers
20 Dec 2014 at 5:55am

By Matthew Mpoke Bigg CONAKRY (Reuters) - U.N. Secretary-General Ban Ki-moon on Saturday urged countries affected by the Ebola virus to avoid discriminating against healthcare workers fighting to end the disease. Ban was speaking in Guinea on the second day of a whistle-stop tour aimed at thanking healthcare workers of the countries at the heart of the epidemic. According to the latest World Health Organization figures, 7,373 people have died of Ebola in the three worst-affected countries, Liberia, Sierra Leone and Guinea. ...


Japan scientists develop micro-fine adhesive sensors
20 Dec 2014 at 2:24am

Scientists in Japan have developed a sticky sheet of tiny sensors that can be put directly on moving joints, beating hearts or other living tissues. "Just by applying to the body like a compress, our novel sheet sensor detects biometric information extremely accurately," researchers at the University of Tokyo said in a statement Friday. The secret is an adhesive gel that prevents a fine grid of sensors from slipping, even if the thing they are in contact with is moving, said the team led by professor Takao Someya at the Department of Electrical Engineering and Information Systems.



American nurse exposed to Ebola released from hospital
20 Dec 2014 at 2:16am

(Reuters) - An American nurse who was exposed to Ebola while volunteering in Sierra Leone was released from the National Institutes of Health's Clinical Center in Maryland on Friday without showing signs of the disease, NIH said. "The patient has shown no clinical or laboratory evidence of Ebola infection and will complete 21 days of monitoring at a private residence in Virginia under the direction of the Virginia Department of Health," NIH said in a statement. ...



UN chief praises Ebola nurses, pledges support during visit
20 Dec 2014 at 12:37am

By Matthew Mpoke Bigg HASTINGS, Sierra Leone (Reuters) - U.N. Secretary General Ban Ki-moon on Friday praised healthcare workers fighting the Ebola virus as he paid his first visit to Liberia and Sierra Leone following an outbreak that has killed nearly 7,000 people. Ban paid tribute to local workers and the United Nations, but he singled out medics from the three countries at the heart of the epidemic who have fallen sick while treating patients. ...


Prepackaged caramel apples linked to 4 deaths
19 Dec 2014 at 5:52pm
WASHINGTON (AP) ? Health officials are warning consumers to avoid prepackaged caramel apples because they are linked to four deaths and more than two dozen illnesses in 10 states.

FDA approves AbbVie combo hepatitis C treatment
19 Dec 2014 at 5:32pm
TRENTON, N.J. (AP) ? Patients with chronic hepatitis C have a new option for treating the liver-damaging virus, with the approval of a combination treatment developed by AbbVie.

U.S. FDA approves AbbVie hepatitis C drug, costs $83,319 for 12 weeks
19 Dec 2014 at 5:02pm
By Caroline Humer (Reuters) - U.S. health regulators on Friday approved AbbVie's all-oral treatment for hepatitis C, and the company said the drug would cost $83,319 for a typical 12-week plan, a bit below its huge selling competitor Solvadi from Gilead Sciences. Gilead's Sovaldi treatment stole headlines last year with its $84,000 price tag and set off a national debate about whether drug prices have climbed too high. AbbVie's newly approved regimen is also less costly than Gilead's newest one-pill regimen that combines Sovaldi with another drug and costs $94,500 for 12 weeks. ...

Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC